Investing
1067 Articles
Markets opened slightly lower this morning and spent the morning trying to decide on a direction. The Reuters/University of Michigan…
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…
A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…
Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke…
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…
Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…
Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The…
Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000…
Earnings season is in full throttle and many major companies are due to report in the week ahead. Some of…
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key…
No industry was able to avoid short selling activity, particularly among its largest companies. Tech, automotive, conglomerates, consumer goods, and…
Now that the 10-Year Treasury Note has been back to close to the 3.00% yields again, we wanted to see…
Our top personal finance-related articles today. Your wallet will thank you later.